A Phase II, Randomized, Open-Label, 52-Week Study of Seladelpar in Patients with Primary Biliary Cholangitis
Christopher L. Bowlus,Michael R. Galambos,Richard J. Aspinall,Gideon M. Hirschfield,David E. J. Jones,Yvonne Doerffel,Stuart C. Gordon,Stephen A. Harrison,Andreas E. Kremer,Marlyn J. Mayo,Paul J. Thuluvath,Cynthia Levy,Mark G. Swain,Guy W. Neff,David A. Sheridan,Carmen M. Stanca,Christoph P. Berg,Aparna Goel,Mitchell L. Shiffman,John M. Vierling,Pol Boudes,Alexandra Steinberg,Yun-Jung Choi,Charles A. McWherter Journal of Hepatology（2022）
关键词
Clinical study,Primary biliary cholangitis,Seladelpar
AI 理解论文
溯源树
样例
